2N03

Solution NMR Structure plectin repeat domain 6 (4403-4606) of Plectin from Homo sapiens, Northeast Structural Genomics Consortium (NESG) Target HR6354E

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	1 mM [U-100% 13C; U-100% 15N; U-2H; ILV-1H] protein, 20 mM MES, 100 mM NaCl, 5 mM CaCl2, 10 mM DTT, 0.02 mM NaN3, 50 uM DSS, 1 ratio protease inhibitor, 90/10 % H2O/D2O	90% H2O/10% D2O	100	6.5	ambient	298
2	2D 1H-13C HSQC aliphatic	1 mM [U-100% 13C; U-100% 15N] protein, 20 mM MES, 100 mM NaCl, 5 mM CaCl2, 10 mM DTT, 0.02 mM NaN3, 50 uM DSS, 1 ratio protease inhibitor, 90/10 % H2O/D2O	90% H2O/10% D2O	100	6.5	ambient	298
3	2D 1H-13C HSQC aromatic	1 mM [U-100% 13C; U-100% 15N] protein, 20 mM MES, 100 mM NaCl, 5 mM CaCl2, 10 mM DTT, 0.02 mM NaN3, 50 uM DSS, 1 ratio protease inhibitor, 90/10 % H2O/D2O	90% H2O/10% D2O	100	6.5	ambient	298
4	3D TROSY-HNCO	1 mM [U-100% 13C; U-100% 15N; U-2H; ILV-1H] protein, 20 mM MES, 100 mM NaCl, 5 mM CaCl2, 10 mM DTT, 0.02 mM NaN3, 50 uM DSS, 1 ratio protease inhibitor, 90/10 % H2O/D2O	90% H2O/10% D2O	100	6.5	ambient	298
5	3D TROSY-HNCA	1 mM [U-100% 13C; U-100% 15N; U-2H; ILV-1H] protein, 20 mM MES, 100 mM NaCl, 5 mM CaCl2, 10 mM DTT, 0.02 mM NaN3, 50 uM DSS, 1 ratio protease inhibitor, 90/10 % H2O/D2O	90% H2O/10% D2O	100	6.5	ambient	298
6	3D TROSY-HN(CO)CA	1 mM [U-100% 13C; U-100% 15N; U-2H; ILV-1H] protein, 20 mM MES, 100 mM NaCl, 5 mM CaCl2, 10 mM DTT, 0.02 mM NaN3, 50 uM DSS, 1 ratio protease inhibitor, 90/10 % H2O/D2O	90% H2O/10% D2O	100	6.5	ambient	298
7	3D TROSY-HNCACB	1 mM [U-100% 13C; U-100% 15N; U-2H; ILV-1H] protein, 20 mM MES, 100 mM NaCl, 5 mM CaCl2, 10 mM DTT, 0.02 mM NaN3, 50 uM DSS, 1 ratio protease inhibitor, 90/10 % H2O/D2O	90% H2O/10% D2O	100	6.5	ambient	298
8	3D HMCM[CG]CBCA	1 mM [U-100% 13C; U-100% 15N; U-2H; ILV-1H] protein, 20 mM MES, 100 mM NaCl, 5 mM CaCl2, 10 mM DTT, 0.02 mM NaN3, 50 uM DSS, 1 ratio protease inhibitor, 90/10 % H2O/D2O	90% H2O/10% D2O	100	6.5	ambient	298
9	3D HMCMCBCA	1 mM [U-100% 13C; U-100% 15N; U-2H; ILV-1H] protein, 20 mM MES, 100 mM NaCl, 5 mM CaCl2, 10 mM DTT, 0.02 mM NaN3, 50 uM DSS, 1 ratio protease inhibitor, 90/10 % H2O/D2O	90% H2O/10% D2O	100	6.5	ambient	298
10	3D [H]-NOESY-[NH/CH] ( mix= 250 ms)	1 mM [U-100% 13C; U-100% 15N; U-2H; ILV-1H] protein, 20 mM MES, 100 mM NaCl, 5 mM CaCl2, 10 mM DTT, 0.02 mM NaN3, 50 uM DSS, 1 ratio protease inhibitor, 90/10 % H2O/D2O	90% H2O/10% D2O	100	6.5	ambient	298
11	3D [(H)C]-NOESY-[CH], ( mix = 250 ms)	1 mM [U-100% 13C; U-100% 15N; U-2H; ILV-1H] protein, 20 mM MES, 100 mM NaCl, 5 mM CaCl2, 10 mM DTT, 0.02 mM NaN3, 50 uM DSS, 1 ratio protease inhibitor, 90/10 % H2O/D2O	90% H2O/10% D2O	100	6.5	ambient	298
12	3D (H)CCH-COSY, aliphatic	1 mM [U-100% 13C; U-100% 15N] protein, 20 mM MES, 100 mM NaCl, 5 mM CaCl2, 10 mM DTT, 0.02 mM NaN3, 50 uM DSS, 1 ratio protease inhibitor, 90/10 % H2O/D2O	90% H2O/10% D2O	100	6.5	ambient	298
13	3D (H)CCH-TOCSY, aliphatic	1 mM [U-100% 13C; U-100% 15N] protein, 20 mM MES, 100 mM NaCl, 5 mM CaCl2, 10 mM DTT, 0.02 mM NaN3, 50 uM DSS, 1 ratio protease inhibitor, 90/10 % H2O/D2O	90% H2O/10% D2O	100	6.5	ambient	298
14	3D [H]-NOESY-[NH/CH] ( mix = 70 ms) #	1 mM [U-100% 13C; U-100% 15N] protein, 20 mM MES, 100 mM NaCl, 5 mM CaCl2, 10 mM DTT, 0.02 mM NaN3, 50 uM DSS, 1 ratio protease inhibitor, 90/10 % H2O/D2O	90% H2O/10% D2O	100	6.5	ambient	298
15	2D ct [13C,1H] HSQC (ct delay 28 ms)	1 mM [U-5% 13C; U-100% 15N] protein, 20 mM MES, 100 mM NaCl, 5 mM CaCl2, 10 mM DTT, 0.02 mM NaN3, 50 uM DSS, 1 ratio protease inhibitor, 90/10 % H2O/D2O	90% H2O/10% D2O	100	6.5	ambient	298
16	2D ct [13C,1H] HSQC (ct delay 42 ms)	1 mM [U-5% 13C; U-100% 15N] protein, 20 mM MES, 100 mM NaCl, 5 mM CaCl2, 10 mM DTT, 0.02 mM NaN3, 50 uM DSS, 1 ratio protease inhibitor, 90/10 % H2O/D2O	90% H2O/10% D2O	100	6.5	ambient	298
17	2D ct [13C,1H] HSQC (ct delay 56 ms)	1 mM [U-5% 13C; U-100% 15N] protein, 20 mM MES, 100 mM NaCl, 5 mM CaCl2, 10 mM DTT, 0.02 mM NaN3, 50 uM DSS, 1 ratio protease inhibitor, 90/10 % H2O/D2O	90% H2O/10% D2O	100	6.5	ambient	298

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Varian	INOVA	750
2	Varian	DDR2	600
3	Bruker	AMX	900

NMR Refinement
Method	Details	Software
torsion angle dynamics, distance geometry		AutoAssign

NMR Ensemble Information
Conformer Selection Criteria	target function
Conformers Calculated Total Number	100
Conformers Submitted Total Number	20
Representative Model	1 (lowest energy)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	data analysis	AutoAssign		Huang, Tejero, Powers and Montelione
2	structure solution	CYANA		Guntert, Mumenthaler and Wuthrich
3	dihedral angles	TALOS		Cornilescu, Delaglio and Bax
4	refinement	Rosetta		(rosetta) -baker david
5	data analysis	CARA		Keller and Wuthrich
6	data processing	PROSA		Guntert
7	refinement	CYANA		Guntert, Mumenthaler and Wuthrich

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.